What is Risperdal?
Risperdal is an anti-psychotic drug first approved by the U.S. Food and Drug Administration in 1993 to treat adults with schizophrenia.
In 2006 and 2007, the FDA approved additional uses for Risperdal, including the treatment of bipolar disorder in adults and juveniles, schizophrenia in children, and certain behavioral symptoms in children with autism.
The Kentucky lawsuit alleged that even though Risperdal was approved for use in children with Attention Deficit Hyperactivity Disorder (ADHD) in 2007, Janssen actively marketed Risperdal to children and the youth market long before the medication was formally approved for that category of patients.
One Risperdal side effect that has occurred in young males is Risperdal gynecomastia, the development of male breasts stemming from a hormonal imbalance triggered by Risperdal.
Risperdal lawsuits brought by males who claim that their Risperdal prescription caused them to develop gynecomastia continue to be filed and move through courts across the U.S.